National Institute of Allergy and Infectious Diseases (NIAID)

6610 Rockledge Drive
20892-6612 Bethesda
USA

www3.niaid.nih.gov

Contact

About National Institute of Allergy and Infectious Diseases

The National Institute of Allergy and Infectious Diseases (NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States and around the world.

Read more about National Institute of Allergy and Infectious Diseases

Facts about National Institute of Allergy and Infectious Diseases Facts about National Institute of Allergy and Infectious Diseases

Industry : Healthcare

News about National Institute of Allergy and Infectious Diseases

20-Aug-2024 | research and development

First-of-its-kind vaccine expands malaria protection for pregnant women

Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years

Read news

30-May-2024 | science

High H5N1 influenza levels found in mice given raw milk from infected dairy cows

Mice administered raw milk samples from dairy cows infected with H5N1 influenza experienced high virus levels in their respiratory organs and lower virus ...

Read news

27-Feb-2020 | science

NIH clinical trial of remdesivir to treat COVID-19 begins

A randomized, controlled clinical trial to evaluate the safety and efficacy of the investigational antiviral remdesivir in hospitalized adults diagnosed ...

Read news

17-Feb-2020 | science

Remdesivir prevents MERS coronavirus disease in monkeys

Results support testing antiviral against 2019 novel coronavirus

Read news

18-Oct-2019 | science

Scientists work toward a rapid point-of-care diagnostic test for Lyme disease

A study published in the Journal of Clinical Microbiology describes a new rapid assay for Lyme disease that could lead to a practical test for use by ...

Read news

28-Jan-2019 | science

Investigational monoclonal antibody to treat Ebola is safe in adults

The investigational Ebola treatment mAb114 is safe, well-tolerated, and easy to administer, according to findings from an early-stage clinical trial. ...

Read news

16-Jul-2018 | science

A 3D structure of 1918 influenza virus-like particles

Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs are not infectious, they show considerable ...

Read news